220 related articles for article (PubMed ID: 25617046)
1. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.
Abenavoli L; Greco M; Nazionale I; Peta V; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):519-27. PubMed ID: 25617046
[TBL] [Abstract][Full Text] [Related]
2. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.
Abenavoli L; Greco M; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805669
[TBL] [Abstract][Full Text] [Related]
3. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
[TBL] [Abstract][Full Text] [Related]
4. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
Loguercio C; Andreone P; Brisc C; Brisc MC; Bugianesi E; Chiaramonte M; Cursaro C; Danila M; de Sio I; Floreani A; Freni MA; Grieco A; Groppo M; Lazzari R; Lobello S; Lorefice E; Margotti M; Miele L; Milani S; Okolicsanyi L; Palasciano G; Portincasa P; Saltarelli P; Smedile A; Somalvico F; Spadaro A; Sporea I; Sorrentino P; Vecchione R; Tuccillo C; Del Vecchio Blanco C; Federico A
Free Radic Biol Med; 2012 May; 52(9):1658-65. PubMed ID: 22343419
[TBL] [Abstract][Full Text] [Related]
5. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.
Trovato FM; Catalano D; Martines GF; Pace P; Trovato GM
Clin Nutr; 2015 Feb; 34(1):86-8. PubMed ID: 24529325
[TBL] [Abstract][Full Text] [Related]
6. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
[TBL] [Abstract][Full Text] [Related]
7. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.
Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G
Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol.
Papamiltiadous ES; Roberts SK; Nicoll AJ; Ryan MC; Itsiopoulos C; Salim A; Tierney AC
BMC Gastroenterol; 2016 Feb; 16():14. PubMed ID: 26831892
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of lifestyle changes in subjects with non-alcoholic liver steatosis and metabolic syndrome may be improved with an antioxidant nutraceutical: a controlled clinical study.
Sorrentino G; Crispino P; Coppola D; De Stefano G
Drugs R D; 2015 Mar; 15(1):21-5. PubMed ID: 25732561
[TBL] [Abstract][Full Text] [Related]
10. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.
Abenavoli L; Milic N; Peta V; Alfieri F; De Lorenzo A; Bellentani S
World J Gastroenterol; 2014 Dec; 20(45):16831-40. PubMed ID: 25492997
[TBL] [Abstract][Full Text] [Related]
11. Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial.
Misciagna G; Del Pilar Díaz M; Caramia DV; Bonfiglio C; Franco I; Noviello MR; Chiloiro M; Abbrescia DI; Mirizzi A; Tanzi M; Caruso MG; Correale M; Reddavide R; Inguaggiato R; Cisternino AM; Osella AR
J Nutr Health Aging; 2017; 21(4):404-412. PubMed ID: 28346567
[TBL] [Abstract][Full Text] [Related]
12. Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot study.
Maciejewska D; Ossowski P; Drozd A; Ryterska K; Jamioł-Milc D; Banaszczak M; Kaczorowska M; Sabinicz A; Raszeja-Wyszomirska J; Stachowska E
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):184-9. PubMed ID: 26408952
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
Federico A; Dallio M; Masarone M; Gravina AG; Di Sarno R; Tuccillo C; Cossiga V; Lama S; Stiuso P; Morisco F; Persico M; Loguercio C
Oxid Med Cell Longev; 2019; 2019():8742075. PubMed ID: 31737175
[TBL] [Abstract][Full Text] [Related]
14. 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease.
Banaszczak M; Maciejewska D; Drozd A; Ryterska K; Milc DJ; Raszeja-Wyszomirska J; Wunsch E; González-Muniesa P; Stachowska E
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32028646
[No Abstract] [Full Text] [Related]
15. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
17. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease.
Aller R; de Luis DA; Izaola O; de la Fuente B; Bachiller R
Eur Rev Med Pharmacol Sci; 2014; 18(7):1041-7. PubMed ID: 24763885
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
[TBL] [Abstract][Full Text] [Related]
19. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Faghihzadeh F; Adibi P; Hekmatdoost A
Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
[TBL] [Abstract][Full Text] [Related]
20. [Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].
Trappoliere M; Federico A; Tuccillo C; de Sio I; Di Leva A; Niosi M; D'Auria M; Loguercio C;
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):193-9. PubMed ID: 15990709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
